Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 TrialShengxiang Ren, Caicun Zhou, Xingxiang Xu et al.|Journal of Thoracic Oncology|2021Cited by 311
Potential regulatory mechanism of TNF-α/TNFR1/ANXA1 in glioma cells and its role in glioma cell proliferationXiaotian Zhu, Donglin Wang|Open Life Sciences|2022Cited by 9